Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: Final data from a multicenter, investigator-blind, randomized study

Leon Kircik, Lawrence Green, Diane Thiboutot, Emil Tanghetti, David Wilson, Sunil Dhawan, Lisa Parr

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Introduction: A solubilized 5% BPO gel has been developed to enhance the bioavailability, follicular penetration, and efficacy of BPO. Methods: Sixty-five patients with moderate facial acne vulgaris were randomly assigned to apply solubilized 5% BPO gel to one facial side and 5% BPO/1% clindamycin to the contralateral side, twice daily for four or 12 weeks. Results: The solubilized BPO gel resulted in significantly greater reductions in non-inflammatory lesion count than BPO/clindamycin at weeks 1, 2, 3, 4 and 12 and comparable reductions in inflammatory lesion count at all time points. Mean values for patient satisfaction with acne improvement were comparable and mean levels of erythema, dryness, peeling, stinging/burning and itching were consistently less than mild. Conclusion: Compared with BPO/clindamycin, the solubilized BPO gel offers significantly greater reductions in non-inflammatory lesion count and comparable reductions in inflammatory lesion count in the absence of an antibiotic.

Original languageEnglish (US)
Pages (from-to)812-818
Number of pages7
JournalJournal of Drugs in Dermatology
Volume8
Issue number9
StatePublished - Sep 1 2009

Fingerprint

Benzoyl Peroxide
Clindamycin
Gels
Research Personnel
Acne Vulgaris
Erythema
Pruritus
Patient Satisfaction
Biological Availability
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Kircik, Leon ; Green, Lawrence ; Thiboutot, Diane ; Tanghetti, Emil ; Wilson, David ; Dhawan, Sunil ; Parr, Lisa. / Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin : Final data from a multicenter, investigator-blind, randomized study. In: Journal of Drugs in Dermatology. 2009 ; Vol. 8, No. 9. pp. 812-818.
@article{94569d44036947a69dd5d44306b76f43,
title = "Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: Final data from a multicenter, investigator-blind, randomized study",
abstract = "Introduction: A solubilized 5{\%} BPO gel has been developed to enhance the bioavailability, follicular penetration, and efficacy of BPO. Methods: Sixty-five patients with moderate facial acne vulgaris were randomly assigned to apply solubilized 5{\%} BPO gel to one facial side and 5{\%} BPO/1{\%} clindamycin to the contralateral side, twice daily for four or 12 weeks. Results: The solubilized BPO gel resulted in significantly greater reductions in non-inflammatory lesion count than BPO/clindamycin at weeks 1, 2, 3, 4 and 12 and comparable reductions in inflammatory lesion count at all time points. Mean values for patient satisfaction with acne improvement were comparable and mean levels of erythema, dryness, peeling, stinging/burning and itching were consistently less than mild. Conclusion: Compared with BPO/clindamycin, the solubilized BPO gel offers significantly greater reductions in non-inflammatory lesion count and comparable reductions in inflammatory lesion count in the absence of an antibiotic.",
author = "Leon Kircik and Lawrence Green and Diane Thiboutot and Emil Tanghetti and David Wilson and Sunil Dhawan and Lisa Parr",
year = "2009",
month = "9",
day = "1",
language = "English (US)",
volume = "8",
pages = "812--818",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "9",

}

Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin : Final data from a multicenter, investigator-blind, randomized study. / Kircik, Leon; Green, Lawrence; Thiboutot, Diane; Tanghetti, Emil; Wilson, David; Dhawan, Sunil; Parr, Lisa.

In: Journal of Drugs in Dermatology, Vol. 8, No. 9, 01.09.2009, p. 812-818.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin

T2 - Final data from a multicenter, investigator-blind, randomized study

AU - Kircik, Leon

AU - Green, Lawrence

AU - Thiboutot, Diane

AU - Tanghetti, Emil

AU - Wilson, David

AU - Dhawan, Sunil

AU - Parr, Lisa

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Introduction: A solubilized 5% BPO gel has been developed to enhance the bioavailability, follicular penetration, and efficacy of BPO. Methods: Sixty-five patients with moderate facial acne vulgaris were randomly assigned to apply solubilized 5% BPO gel to one facial side and 5% BPO/1% clindamycin to the contralateral side, twice daily for four or 12 weeks. Results: The solubilized BPO gel resulted in significantly greater reductions in non-inflammatory lesion count than BPO/clindamycin at weeks 1, 2, 3, 4 and 12 and comparable reductions in inflammatory lesion count at all time points. Mean values for patient satisfaction with acne improvement were comparable and mean levels of erythema, dryness, peeling, stinging/burning and itching were consistently less than mild. Conclusion: Compared with BPO/clindamycin, the solubilized BPO gel offers significantly greater reductions in non-inflammatory lesion count and comparable reductions in inflammatory lesion count in the absence of an antibiotic.

AB - Introduction: A solubilized 5% BPO gel has been developed to enhance the bioavailability, follicular penetration, and efficacy of BPO. Methods: Sixty-five patients with moderate facial acne vulgaris were randomly assigned to apply solubilized 5% BPO gel to one facial side and 5% BPO/1% clindamycin to the contralateral side, twice daily for four or 12 weeks. Results: The solubilized BPO gel resulted in significantly greater reductions in non-inflammatory lesion count than BPO/clindamycin at weeks 1, 2, 3, 4 and 12 and comparable reductions in inflammatory lesion count at all time points. Mean values for patient satisfaction with acne improvement were comparable and mean levels of erythema, dryness, peeling, stinging/burning and itching were consistently less than mild. Conclusion: Compared with BPO/clindamycin, the solubilized BPO gel offers significantly greater reductions in non-inflammatory lesion count and comparable reductions in inflammatory lesion count in the absence of an antibiotic.

UR - http://www.scopus.com/inward/record.url?scp=70349327580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349327580&partnerID=8YFLogxK

M3 - Article

C2 - 19746673

AN - SCOPUS:70349327580

VL - 8

SP - 812

EP - 818

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 9

ER -